Ferrante Karen Jean 4
4 · Cogent Biosciences, Inc. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
Ferrante Karen Jean
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-05+44,700→ 44,700 totalExercise: $8.92Exp: 2034-06-05→ Common Stock (44,700 underlying)
Footnotes (1)
- [F1]This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders.